Biography
VIVEK MITTAL, Ph.D.
Dr. Vivek Mittal, an internationally recognized cancer researcher is the Director of the Lehman Brothers Lung Cancer Laboratory. His group is actively engaged in understanding mechanisms of tumor progression and metastasis.Dr. Mittal and colleagues have published seminal papers describing the role of bone marrow cells in regulating the "angiogenic switch" which is critical in mediating progression of primary tumors, initiation of metastasis and development of micrometastasis to life threatening macrometastases in the lung.Previously, Dr. Mittal held appointments in the faculties of Cold Spring Harbor Laboratory and State University of New York, Stony Brook. He lectures widely to diverse audiences throughout the world and has been published in leading journals including Science, Nature, Cancer Cell, PNAS, and other leading peer-reviewed journals and text books. His research is supported by funds from the National Cancer Institute and private foundations, and several national and international patents have emerged from his discoveries.
PRIMARY APPOINTMENTS
1994-1995 Post Doctoral Fellow (Laboratory of Nouria Hernandez), Cold Spring Harbor Laboratory, NY
1995-1999 HHMI Research Associate (Laboratory of Nouria Hernandez), Cold Spring Harbor Laboratory, NY
1999-2000 Research Investigator (Laboratory of Michael Wigler), Cold Spring Harbor Laboratory, NY
2001-2008 Assistant Professor, Cold Spring Harbor Laboratory, NY
2008- Associate Professor, Cardiothoracic Surgery, Weill Cornell Medical Center Director, Lehman Brothers Lung Cancer Laboratory, Weill Cornell Medical Center
OTHER PROFESSIONAL ACTIVITIES
2000-2003 Scientific Advisor, CSHL Microarray Resource
2001-2003 Scientific Advisory Board Member (Microarrays) AMDeC, NY
2004-2005 Admission Committee Member, Undergraduate Research Program, CSHL
2005-2006 Selection Committee/Research Mentor, Undergraduate Research Program, Cold Spring Harbor Laboratory, NY
2005- 2006 Genetics/MCB admissions committee, Stony Brook University
2000- 2007 Faculty, Watson School of Biological Science, CSHL, NY.
2002- 2007 Adjunct Faculty, Genetics Program. Stony Brook University, NY2005- Adjunct Faculty, Molecular and Cellular Biology, Stony Brook University, NY
2002-2002 Adjunct Faculty, Long Island University, Brookville, NY
2004- Scientific Advisor, Protein Lounge, Complete systems Biology, SanDeigo, CA
1999-2001 Consultant on Genomics and Cancer, Narragansett Asset Management, LLC., NY.
2004- Consultant, Biomedical Science, Gerson Lehrman Group, & Council of Health care advisors. NY
2005 Organizer/Chairperson of a Workshop. AACR 96th Annual Meeting, Annheim, CA.
2007 Scientific Advisory Board Member, Bioalvo (a drug discovery company), Portugal
EXTRAMURAL, PROFESSIONAL RESPONSIBILITIES
Reviewer on Special Emphasis Panel, NCI Program Project (P01), Discovery and Development P01, NIH/NCI grants (2007, 2008, 2009)
Reviewer on Special Emphasis Panel, NCI Program Project (U01), Collaborative research in Integrative cancer biology and tumor mocroenvironment , NIH/NCI grants (2010)
Reviewer for journals including, PNAS, Nature Chemical Biology, & Nucleic Acids Research, Oncogene, EMBO Journal, Genesand Development, International Journal of Cancer, Cancer Research.
Lead Lecturer, Advance course on Oncobiology, Ph. D program, Center for neuroscience andneurobiology, University of Coimbra. Portugal (2008- )
PROFESSIONAL MEMBERSHIPS
New York Academy of Science (NYAS) 2003- American Association for Cancer Research (AACR) 2002- American Association for Advancement of Science (AAAS) 1996-2004 North American Vascular Biology Organization (NAVBO) 2006 -
